Form 8-K - Current report:
SEC Accession No. 0001070081-19-000030
Filing Date
2019-06-03
Accepted
2019-06-03 16:43:55
Documents
3
Period of Report
2019-05-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k6319.htm 8-K 28762
2 EXHIBIT 99.1 a2019-06x03ptctcfoannounce.htm EX-99.1 9287
3 a20190603ptctcfoannou_image1.gif GRAPHIC 5964
  Complete submission text file 0001070081-19-000030.txt   47771
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 19873839
SIC: 2834 Pharmaceutical Preparations